Drugs / LT5001
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04393675 Comparator | May 2020 → Sep 2022 | — | Lumosa Therapeutics Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LT5001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04393675 ↗ |